Zobrazeno 1 - 10
of 55
pro vyhledávání: '"flg gene"'
Publikováno v:
Indian Journal of Dermatology, Vol 68, Iss 2, Pp 135-140 (2023)
Background: Mutations in the filaggrin (FLG) gene has been reported to be an indicator of poor prognosis of atopic dermatitis (AD). It has been reported that there is a considerable variation in the mutations detected in the FLG gene in different eth
Externí odkaz:
https://doaj.org/article/063b1bd8d2264acc827ba46bc72b9b1d
Congenital ichthyosiform erythroderma with epidermolysis due to a novel frameshift mutation in KRT10
Autor:
Bernadett Kurz, MD, Kevin-Thomas Koschitzki, MD, Ute Hehr, MD, Ute Germer, MD, Julia Schreml, MD, Florian Langhammer, MD, Stephan Schreml, MD
Publikováno v:
JAAD Case Reports, Vol 35, Iss , Pp 74-76 (2023)
Externí odkaz:
https://doaj.org/article/9dc6b089fb0a42dda0a9ce5430fa2403
Publikováno v:
South African Family Practice, Vol 60, Iss 6, Pp 26-33 (2018)
The aetiology of atopic dermatitis is multi-faceted and affects our first line host defence, the skin. Atopic dermatitis has a significant influence on a patient’s social and occupational functioning and can have long-lasting effects. The signs and
Externí odkaz:
https://doaj.org/article/d658776b32c34fb79004d0695464578e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Congenital ichthyosiform erythroderma with epidermolysis due to a novel frameshift mutation in KRT10
Autor:
Kurz, Bernadett, Koschitzki, Kevin-Thomas, Hehr, Ute, Germer, Ute, Schreml, Julia, Langhammer, Florian, Schreml, Stephan
Publikováno v:
JAAD Case Rep
Neonatal erythroderma (NE) is an erythema that covers at least 90% of the body surface and occurs at birth or in the first 4 postnatal weeks.1 The incidence of NE in patients in the Netherlands has been estimated by dermatologists to be 10 per 100,00
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1216784e3bc428b074613551269bca02
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of Epidemiology. 50
Background Eczema is a common inflammatory skin disease with varying developmental trajectories/patterns. This study sought to investigate eczema development from infancy to early adulthood by identifying distinct developmental trajectories that desc
Publikováno v:
JAAD Case Reports
Autor:
Marek Gierlinski, Sara J. Brown, William V. Nicholson, Angus I. Lamond, Christian Cole, Susan E. Bray, Judit Remenyi, James Abbott, John A. McGrath, Sara ten Have, Sheila C. Wright, Mateusz Glok, Martina S. Elias, Alan R. Prescott, Sharon Edwards, Phillip D. Whitfield, Lavinia Paternoster
Publikováno v:
The Journal of Allergy and Clinical Immunology
Elias, M S, Wright, S C, Remenyi, J, Abbott, J C, Bray, S E, Cole, C, Edwards, S, Gierlinski, M, Glok, M, McGrath, J A, Nicholson, W V, Paternoster, L, Prescott, A R, Have, S T, Whitfield, P D, Lamond, A I & Brown, S J 2019, ' EMSY expression affects multiple components of the skin barrier with relevance to atopic dermatitis ', Journal of Allergy and Clinical Immunology, vol. 144, no. 2, pp. 470-481 . https://doi.org/10.1016/j.jaci.2019.05.024
Elias, M S, Wright, S C, Remenyi, J, Abbott, J C, Bray, S E, Cole, C, Edwards, S, Gierlinski, M, Glok, M, McGrath, J A, Nicholson, W V, Paternoster, L, Prescott, A R, Have, S T, Whitfield, P D, Lamond, A I & Brown, S J 2019, ' EMSY expression affects multiple components of the skin barrier with relevance to atopic dermatitis ', Journal of Allergy and Clinical Immunology, vol. 144, no. 2, pp. 470-481 . https://doi.org/10.1016/j.jaci.2019.05.024
Background Atopic dermatitis (AD) is a common, complex, and highly heritable inflammatory skin disease. Genome-wide association studies offer opportunities to identify molecular targets for drug development. A risk locus on chromosome 11q13.5 lies be